iSpecimen Inc
NASDAQ:ISPC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
iSpecimen Inc
Retained Earnings
iSpecimen Inc
Retained Earnings Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
iSpecimen Inc
NASDAQ:ISPC
|
Retained Earnings
-$82.4m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Retained Earnings
$4.4B
|
CAGR 3-Years
25%
|
CAGR 5-Years
27%
|
CAGR 10-Years
41%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Retained Earnings
-$146.5m
|
CAGR 3-Years
23%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Retained Earnings
$186.9m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Retained Earnings
$384.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
14%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Retained Earnings
-$108.8m
|
CAGR 3-Years
9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
iSpecimen Inc
Glance View
iSpecimen, Inc. operates as healthcare organization that engages in procurement of human biospecimens. The company is headquartered in Lexington, Massachusetts and currently employs 59 full-time employees. The company went IPO on 2021-06-17. The firm designed iSpecimen Marketplace platform to transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. The Company’s marketplace platform ingests de-identified healthcare data provided by healthcare supply partners. The iSpecimen Marketplace supports the supply chain management and bioprocurement process for specimens and associated data. The Company’s platform helps with administrating and reporting function for researchers, suppliers, and internal personnel, including user and compliance management. The firm serves to biopharmaceutical companies, in vitro diagnostic (IVD) companies, and government/academic institutions.
See Also
What is iSpecimen Inc's Retained Earnings?
Retained Earnings
-82.4m
USD
Based on the financial report for Dec 31, 2025, iSpecimen Inc's Retained Earnings amounts to -82.4m USD.
What is iSpecimen Inc's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-23%
Over the last year, the Retained Earnings growth was -15%. The average annual Retained Earnings growth rates for iSpecimen Inc have been -19% over the past three years , -23% over the past five years .
